Preparing method of core-shell structure drug carrier with near-infrared light exciting supermolecule valve light control drug release
A core-shell structure, near-infrared light technology, which is applied in the photodissociation of drugs in the body, medical preparations of inactive ingredients, inactive ingredients of polymer compounds, etc. Controlled release and other issues to achieve the effect of strong biological penetration and small cell damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0031] Specific Embodiment 1: The preparation method of a core-shell structure drug carrier of a near-infrared light-excited supramolecular valve light-controlled drug release in this embodiment is specifically carried out according to the following steps:
[0032] 1. Synthesis of upconversion nanoparticle core: NaYF 4 : Yb / Tm up-conversion nanoparticles are dispersed in cyclohexane to obtain up-conversion nanoparticles cores;
[0033] 2. Synthesis of up-conversion nanoparticles coated with shells: adding oleic acid, octadecene and the up-conversion nanoparticles core obtained in step 1 to yttrium chloride hexahydrate to obtain a reaction system, under the conditions of argon protection and stirring The temperature of the reaction system was raised from room temperature to 160°C, and stirred for 1.5h under the protection of argon at a temperature of 160°C, then the temperature was naturally cooled from 160°C to 50°C, then the mixed solution A was added, and then Stir for 0.5h...
specific Embodiment approach 2
[0044] Specific embodiment two: the difference between this embodiment and specific embodiment one is that the volume ratio of the mass of yttrium chloride hexahydrate described in step two to oleic acid is 1mg:0.035mL. Other steps and parameters are the same as those in the first embodiment.
specific Embodiment approach 3
[0045] Specific embodiment three: this embodiment is different from specific embodiment one or two in that: the volume ratio of the mass of yttrium chloride hexahydrate described in step two to octadecene is 1mg:0.098mL. Other steps and parameters are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com